Literature DB >> 11221905

Dramatic improvement of severe acute disseminated encephalomyelitis after treatment with intravenous immunoglobulin in a three-year-old boy.

J B Andersen, L H Rasmussen, M Herning, A Paerregaard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11221905     DOI： 10.1017/s0012162201220258

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN： 0012-1622            Impact factor:   5.449


× No keyword cloud information.
  4 in total

Review 1.  [Acute disseminated encephalomyelitis. Pathogenesis, diagnosis, treatment, and prognosis].

Authors:  O Stüve; S Nessler; H P Hartung; B Hemmer; H Wiendl; B C Kieseier
Journal:  Nervenarzt       Date:  2005-06       Impact factor: 1.214

Review 2.  Evidence for the use of intravenous immunoglobulins--a review of the literature.

Authors:  Shaye Kivity; Uriel Katz; Natalie Daniel; Udi Nussinovitch; Neophytos Papageorgiou; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2010-04       Impact factor: 8.667

3.  Treatment of acute disseminated encephalomyelitis.

Authors:  Daniela Pohl; Silvia Tenembaum
Journal:  Curr Treat Options Neurol       Date:  2012-06       Impact factor: 3.972

4.  Refractory Fulminant Acute Disseminated Encephalomyelitis (ADEM) in an Adult.

Authors:  Federico Rodríguez-Porcel; Alejandro Hornik; Jordan Rosenblum; Ewa Borys; José Biller
Journal:  Front Neurol       Date:  2014-12-23       Impact factor: 4.003
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.